Martin Burns, CEO of Bruin Biometrics is a former management consultant who worked with Deloitte and PwC and has also served as a guest lecturer at UCLA Anderson School of Management, where he taught entrepreneurship in biotechnology

At Bruin, Martin is leading the charge to bring pressure injury (bedsore) prevention into the 21st century. Bedsores are entirely preventable yet remain one of the most under-discussed threats in hospitals today, especially among patients with darker skin tones who are often overlooked by traditional visual assessments

In this episode, Martin explains why a biology-first approach is needed to tackle these “silent killers,” the major cultural and systemic hurdles to adoption, and why he believes sensor technology should become as routine as checking blood oxygen levels. We also explore investor skepticism, the importance of diverse clinical validation and the operational realities of implementing new technologies in hospitals without disrupting workflows

Timestamps:

[00:00:18] What Are Pressure Injuries and Why They’re Deadly

[00:02:12] The Moment Martin Saw the Real Problem

[00:03:58] The Biology of Subepidermal Moisture

[00:06:53] Turning a Science Project into a Scalable Product

[00:10:06] Why Traditional Risk Assessments Fail

[00:12:41] Addressing Skin Tone Bias in Wound Care

[00:17:14] From Skepticism to Adoption: Changing Clinical Culture

[00:21:55] Beyond Bedsores: Future Sensor Applications

[00:24:17] The Nurse Assistant That Frees Up Hours

[00:26:52] Mountains, Gym Days & Recharging Outside Work

Get in touch with Martin - https://www.linkedin.com/in/martin-burns-9391a57/

Learn more about Bruin - https://sem-scanner.com/

Get in touch with Karandeep Badwal - https://www.linkedin.com/in/karandeepbadwal/

Follow Karandeep on YouTube - https://www.youtube.com/@KarandeepBadwal

Subscribe to the Podcast

Julio G. Martinez-Clark CEO of Bioaccess and President of IAOCR/GCSA Americas is a MedTech trailblazer helping startups accelerate First-in-Human (FIH) clinical trials across Latin America, with over 20 years of experience spanning healthcare, telecom and venture capital

In this episode, we unpack why more MedTech companies are turning to LATAM for faster, more cost-effective trial execution. Julio shares how his Miami-based CRO helps deliver 58-day CE mark approvals, his experience supporting 100+ device startups and why time, not money, is the most precious currency for early-stage founders. We also touch on trial quality, regulatory strategy and why he believes Latin America will play a defining role in the next era of global MedTech innovation

Timestamps:

[00:00:47] Why LATAM Is the Next MedTech Trial Hub

[00:02:21] The Problem with FIH Trials in the U.S.

[00:04:42] How bioaccess® Reduces Approval Timelines by 70%

[00:06:01] Strategic Sites, Patient Retention & CRO Infrastructure

[00:08:17] Do LATAM Trials Hold Up to FDA & EU Scrutiny?

[00:10:43] The Fundraising Pressure Behind Faster Clinical Results

[00:12:22] Founder Mistakes in In-House Trial Management

[00:14:11] Why LATAM May Overtake Eastern Europe in FIH Volume

[00:17:26] Regulatory Standards, UNESCO, and Regional Quality

[00:20:10] Julio Outside the Office: Family, Fitness & Podcasting

Get in touch with Julio - https://www.linkedin.com/in/juliomartinezclark/

Learn more about Bioaccess - https://www.bioaccessla.com/

Get in touch with Karandeep Badwal - https://www.linkedin.com/in/karandeepbadwal/

Follow Karandeep on YouTube - https://www.youtube.com/@KarandeepBadwal

Subscribe to the Podcast

Mark Fox founder and CEO of Resona Health is a former NASA space shuttle engineer turned wellness-tech entrepreneur. From designing spacecraft to pioneering wearable PEMF (Pulsed Electromagnetic Field) therapy, Mark brings a rare blend of hardcore engineering and holistic healthcare innovation

In this episode, we dive deep into the world of energy medicine from the scientific foundations of PEMF and resonance frequency therapy to its real-world impact on mental clarity, emotional regulation and chronic pain. Mark also walks us through the uphill battle with FDA compliance, the hidden power of vagus nerve stimulation and the unexpected physics that connect hot air balloons to healthcare innovation. It's a fascinating mix of engineering, wellness tech and startup grit

Timestamps:

[00:00:35] From NASA to Neuromodulation: Mark’s Origin Story

[00:03:05] What Is PEMF Therapy? Explaining the Basics

[00:05:48] The New Vagus Nerve Device: Chest vs Neck Placement

[00:08:40] Why Frequency > Voltage: Ditching Electrodes for Fields

[00:11:22] How Resona Built a 98% Success Rate with Pocket PEMF

[00:13:33] Frequency over Pharma: A Founder’s Clinical Pivot

[00:16:02] The Compliance Trap: How the FDA Deals With Wellness Claims

[00:18:50] Using GPTs for Regulatory Copywriting (and Staying Legal)

[00:21:10] What the Body Teaches You When You Build for It

[00:24:16] Life Outside of Resona: Flying, Sailing and Freedom to Tinker

Get in touch with Mark - https://www.linkedin.com/in/mark-fox-ab589110/ & https://resona.health/

Get in touch with Karandeep Badwal - https://www.linkedin.com/in/karandeepbadwal/

Follow Karandeep on YouTube - https://www.youtube.com/@KarandeepBadwal